logo
episode-header-image
Aug 2024
22m 30s

The chips are down: will diet drugs devo...

The Economist
About this episode

Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And why it’s time to revive the siesta (17:11).


Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+


For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. 


Hosted on Acast. See acast.com/privacy for more information.

Up next
Aug 22
Rule and divide: opposition grows in Syria
Less than nine months after Syria’s dictator Bashar al-Assad was toppled, the honeymoon is over. How is the new regime responding to rising dissent? Introducing Britain’s revolutionary retirees: why pensioners increasingly dominate political protest. And celebrating the life of o ... Show More
23m 38s
Aug 21
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
Aug 20
Trouble in paradise: US plans for Pacific war
With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ... Show More
22m 34s
Recommended Episodes
Oct 2024
Hot shot: the wider promise of weight-loss jabs
First they treated diabetes. Then obesity. Now GLP-1 drugs are being tested on a range of other diseases too. Though the US economy is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants are maki ... Show More
23m 58s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
Dec 2024
A Turning Point for Ultraprocessed Foods
A new study has found that nearly three-quarters of American adults are now obese or overweight, and there’s growing concern — among politicians, scientists and consumers — about one potential culprit: ultraprocessed foods.Guest: Alice Callahan, a nutrition and health reporter fo ... Show More
29m 52s
May 19
May-poll dance: Poland’s presidential race
Rafal Trzaskowski, the liberal mayor expected to win the first round cleanly only squeaked by. We ask what’s at stake in the NATO-front-line country now the second round looks so uncertain. In the new world of weight-loss drugs Wegovy, from Novo Nordisk, has reigned supreme—perha ... Show More
22m 29s
Jul 23
The smaller C: progress in beating cancer
Overall, more people are dying from cancer. But a closer look at the numbers reveals just how much success modern medicine has had at making the disease less deadly. The spiraling fortunes of Kraft Heinz since its formation from a merger is a sign of a wider malaise in the food i ... Show More
21m 56s
Apr 2025
Doomed traders: Trump’s tariff fallout
Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ... Show More
21m 20s
Dec 2024
The Sunday Read: ‘Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.’
For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain.Around seve ... Show More
28m 6s
Aug 21
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
May 5
Reversing Inflammation, Power Naps & The Fall of Weight Watchers/Diet Culture
In this week’s episode of The Wellness Scoop, we’re diving into some of the biggest shifts and studies shaping the future of health and wellness. We look at a powerful new study showing how switching to a traditional diet for just two weeks can reduce inflammation and boost immun ... Show More
1h 6m
Jun 12
Same news story: why Murdoch endures
The all-famous Murdoch clan is engaged in a fierce battle over control of the family’s media companies. Our correspondent explains why turmoil at the top has not deterred investors. After decades of fruitless research into Alzheimer’s, there are finally some new drugs in the pipe ... Show More
18m 57s